Peripheral Vascular Devices | Market Insights | Europe (Supplemental) | 2022
While the COVID-19 pandemic will have a negative impact on the European peripheral vascular device market in the short term, the dynamic nature of the PV market, the launch of novel premium-price products backed by clinical data, and improvement in reimbursement will lead to steady growth through the remainder of forecast period. However, revenue growth will be limited to some extent due to increasing price competition and ongoing cost constraints in the region.
This Medtech 360 report provides high-level market metrics for PV devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across an 11-year period.
